Related references
Note: Only part of the references are listed.Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy A Randomized Clinical Trial
Caroline J. Coats et al.
JAMA CARDIOLOGY (2019)
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee
Steven M. Hollenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
Thomas Beiert et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure
Laura C. van Vark et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Defective Branched-Chain Amino Acid Catabolism Disrupts Glucose Metabolism and Sensitizes the Heart to Ischemia-Reperfusion Injury
Tao Li et al.
CELL METABOLISM (2017)
Assessing Cardiac Metabolism A Scientific Statement From the American Heart Association
Heinrich Taegtmeyer et al.
CIRCULATION RESEARCH (2016)
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
Wynn G. Hunter et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure Diagnostic and Prognostic Value of Metabolomics
Mei-Ling Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Metabolomic approach to profile functional and metabolic changes in heart failure
Martino Deidda et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
Quantitative acylcarnitine determination by UHPLC-MS/MS Going beyond tandem MS acylcarnitine profiles
Paul E. Minkler et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Metabolomics signature improves the prediction of cardiovascular events in elderly subjects
S. Rizza et al.
ATHEROSCLEROSIS (2014)
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
Sayanti Bhattacharya et al.
ATHEROSCLEROSIS (2014)
Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing Heart A Multisystems Approach
Ling Lai et al.
CIRCULATION-HEART FAILURE (2014)
Disturbed carnitine regulation in chronic heart failure - Increased plasma levels of palmitoyl-carnitine are associated with poor prognosis
Thor Ueland et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis
James J. DiNicolantonio et al.
MAYO CLINIC PROCEEDINGS (2013)
Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry
Paul E. Minkler et al.
CLINICAL CHEMISTRY (2008)
Determination of the reference range of endogenous plasma carnitines in healthy adults
Stephanie E. Reuter et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inflammation and perturbation of the L-carnitine system in heart failure
G Vescovo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease
C Vitale et al.
EUROPEAN HEART JOURNAL (2004)
Myocardial function and energy metabolism in carnitine-deficient rats
CE Zaugg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
The role of carnitine in myocardial dysfunction
DF Pauly et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
A standardized definition of ischemic cardiomyopathy for use in clinical research
GM Felker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy
SR Bergmann et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Lethal cardiac tachyarrhythmia in a patient with neonatal carnitine-acylcarnitine translocase deficiency
K Choong et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2001)
Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure
MA Martín et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum
KA Yamada et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
